Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cerelixis developing precision crop protection products that optimize plant growth & improve resilience to adverse environmental conditions.
Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
FÆRM is a food technology company.
NorFalk is a biotech company that produces bio-based, sustainable surfactants for applications in consumer everyday products.
Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.
BioInnovation Institute Venture Lab has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute Venture Lab's top investment sectors include Biotechnology, AgTech, Chemical, Chemical Engineering, Food and Beverage. The firm invests across 10 different industry categories.
Among tracked funding rounds, FÆRM received $1.4M in a Convertible Note round. BioInnovation Institute Venture Lab's total known invested capital is $47.3M.
BioInnovation Institute Venture Lab's average investment size is $1.0M across its portfolio of 53 companies.
Recent BioInnovation Institute Venture Lab portfolio additions include Cerelixis, xterna, FÆRM, NorFalk, Amplify Therapeutics. These companies were founded in 2020 or later.